Within the last few decades, in response to the advent of potent and versatile therapeutic agents, the diversity of conventional ophthalmic formulations has gradually evolved, extending well beyond simple solutions, and now includes a variety of types of drug administration. We can develop new formulations or improve existing drugs formulations which are able to overcome ocular barriers in order to optimize bioavailability.